Kushal Chakraborty
Overview
Explore the profile of Kushal Chakraborty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
193
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mondal J, Chakraborty K, Bunggulawa E, An J, Revuri V, Nurunnabi M, et al.
J Control Release
. 2024 Jun;
372:1-30.
PMID: 38849092
Breast cancer is the most prevalent cancer among women and the leading cause of cancer-related deaths in this population. Recent advances in Immunotherapy, or combined immunotherapy, offering a more targeted...
2.
Chakraborty K, Mondal J, An J, Park J, Lee Y
Pharmaceutics
. 2023 Mar;
15(3).
PMID: 36986832
Radiopharmaceutical therapy, which can detect and treat tumours simultaneously, was introduced more than 80 years ago, and it has changed medical strategies with respect to cancer. Many radioactive radionuclides have...
3.
Mondal J, An J, Surwase S, Chakraborty K, Sutradhar S, Hwang J, et al.
Biosensors (Basel)
. 2022 Sep;
12(9).
PMID: 36140116
After the COVID-19 pandemic, the development of an accurate diagnosis and monitoring of diseases became a more important issue. In order to fabricate high-performance and sensitive biosensors, many researchers and...
4.
Lee J, Lee J, Chakraborty K, Hwang J, Lee Y
RSC Adv
. 2022 Jul;
12(29):18475-18492.
PMID: 35799926
In the past few decades, scientists have actively worked on developing effective drug delivery systems (DDSs) as means to control life-threatening diseases and challenging illnesses. In order to develop such...
5.
Hwang S, Chakraborty K, An J, Mondal J, Yoon H, Lee Y
Pharmaceutics
. 2021 Nov;
13(11).
PMID: 34834290
Drug delivery to tumor sites using nanotechnology has been demonstrated to overcome the drawbacks of conventional anticancer drugs. Altering the surface shape and geometry of nanocomposites alters their chemical properties,...
6.
Acute toxicity of subcutaneously administered vitamin E isomers delta- and gamma-tocotrienol in mice
Swift S, Pessu R, Chakraborty K, Villa V, Lombardini E, Ghosh S
Int J Toxicol
. 2014 Oct;
33(6):450-8.
PMID: 25355734
The toxicity of parenterally administered vitamin E isomers, delta-tocotrienol (DT3) and gamma-tocotrienol (GT3), was evaluated in male and female CD2F1 mice. In an acute toxicity study, a single dose of...
7.
Kulkarni S, Chakraborty K, Kumar K, Kao T, Hauer-Jensen M, Ghosh S
ISRN Radiol
. 2014 Jun;
2013:390379.
PMID: 24959559
Purpose. This study was designed to determine the efficacy and mechanisms of radioprotection by the combination of gamma-tocotrienol (GT3) and pentoxifylline (PTX) against acute radiation injury. Materials and Methods. Post-irradiation...
8.
Suman S, Datta K, Chakraborty K, Kulkarni S, Doiron K, Fornace Jr A, et al.
Food Chem Toxicol
. 2013 Aug;
60:488-96.
PMID: 23941772
Gamma tocotrienol (GT3) has been reported as a potent ameliorator of radiation-induced gastrointestinal (GI) toxicity when administered prophylactically. This study aimed to evaluate the role of GT3 mediated pro- and...
9.
Ray S, Kulkarni S, Chakraborty K, Pessu R, Hauer-Jensen M, Kumar K, et al.
Int Immunopharmacol
. 2013 Feb;
15(3):557-64.
PMID: 23415908
Gamma-tocotrienol (GT3), a vitamin E isoform, is shown to induce high levels of granulocyte colony stimulating factor (G-CSF) in mice. G-CSF is a key cytokine used for stimulation of hematopoiesis,...
10.
Ghosh S, Singh R, Chakraborty K, Kulkarni S, Uppal A, Luo Y, et al.
Mol Biosyst
. 2013 Feb;
9(4):723-31.
PMID: 23403731
Exposure to ionizing radiation (IR) elicits a set of complex biological responses involving gene expression and protein turnover that ultimately manifest as dysregulation of metabolic processes representing the cellular phenotype....